| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TNDM | Common Stock | Options Exercise | $51K | +1.5K | $34.00 | 1.5K | Feb 1, 2022 | Direct | F1 | |
| transaction | TNDM | Common Stock | Sale | -$35K | -300 | -20% | $116.63 | 1.2K | Feb 1, 2022 | Direct | F2, F3 |
| transaction | TNDM | Common Stock | Sale | -$78.6K | -667 | -55.58% | $117.89 | 533 | Feb 1, 2022 | Direct | F2, F4 |
| transaction | TNDM | Common Stock | Sale | -$63.3K | -533 | -100% | $118.82 | 0 | Feb 1, 2022 | Direct | F2, F5 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TNDM | Stock Option | Options Exercise | $51K | +1.5K | +4.7% | $34.00 | 33.4K | Feb 1, 2022 | Common Stock | 1.5K | $34.00 | Direct | F6, F7 |
| Id | Content |
|---|---|
| F1 | Represents shares of common stock received upon exercise of a stock option award. |
| F2 | The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2021. |
| F3 | The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $116.33 to $116.99. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. |
| F4 | The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $117.46 to $118.29. The Reporting Person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. |
| F5 | The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $118.52 to $119.50. The Reporting Person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. |
| F6 | The option shall vest in 36 equal monthly installments from January 2, 2019, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). |
| F7 | The expiration date for these options is 10 years from the date of grant. |